Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1494-1502

  Pöhlmann, Stefan ^a   Stolte, Nicole ^b   Münch, Jan ^a   Ten Haaft, Peter ^c   Heeney, Jonathan L ^c   Stahl Hennig, Christiane ^b   Kirchhoff, Frank ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOPATHOGENESIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RECEPTOR BINDING; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE; GENES, ENV; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; RECEPTORS, CCR5; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECEPTORS, VIRUS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0032703757     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315097     Document Type: Article

References (48)

1. 1. D'Souza MP, Harden VA. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat Med 1996;2:1293-300.
2. 2. Unutmaz D, KewalRamani VN, Littman DR. G protein-coupled receptors in HIV and SIV entry: new perspectives on lentivirus-host interactions and on the utility of animal models. Semin Immunol 1998;10:225-36.
3. 3. Bieniasz PD, Cullen BR. Chemokine receptors and human immunodeficiency virus infection. Front Bioscience 1998;3:44-58.
4. 4. Alkhatib G, Combadiere C, Broder CC, et al. CC-CKR5: a RANTES, MIP-Iα, MIP-Iβ receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
5. 5. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85: 1135-48.
6. 6. Choe, H, Farzan M, Konkel M, et al. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dual tropic human immunodeficiency virus type 1. J Virol 1998;72:6113-8.
7. 7. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
8. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
9. 9. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein coupled receptor. Science 1996;272:872-7.
10. 10. Alkhatib G, Liao F, Berger EA, Farber JM, Peden KW. A new SIV coreceptor, STRL33 [letter]. Nature 1997;388:238.
11. 11. Berger EA. HIV entry and tropism: the chemokine receptor connection. AIDS 1997;11(Suppl):S3-16.
12. 12. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
13. 13. Rucker J, Edinger AL, Sharron M, et al. Utilization of chemokine receptors, orphan receptors, and herpesvinis-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 1997;71:8999-9007.
14. 14. Owen SM, Ellenberger D, Rayfield M, et al. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol 1998;72:5425-32.
15. 15. Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997;185:2015-23.
16. 16. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
17. 17. Farzan M, Choe H, Martin K, et al. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 1997;186:405-11.
18. 18. Zhang L, He T, Huang Y, et al. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol 1998;72: 9307-12.
19. 19. Zhang YJ, Dragic T, Cao Y, et al. Use of coreceptors other than CCR5 by non-syncytium inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J Virol 1998;72:9337-44.
20. 20. Pöhlmann S, Krumbiegel M, Kirchhoff F. Coreceptor usage of BOB/GPR-15 and BONZO/STRL-33 by primary HIV-1 isolates. J Gen Virol 1999; 80:1241-51.
21. 21. Mörner A, Björndal A, Albert J, et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 1999;73:2343-9.
22. 22. Desrosiers RC, Ringler DJ. Use of SIV for AIDS research. Intervirology 1989;30:301-12.
23. 23. Gao F, Yue L, White AT. Human infection by genetically diverse SIVSM-related HIV-2 in West Africa. Nature 1992;358:495-9.
24. 24. Sharp PM, Robertson DL, Hahn BH. Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci 1995;349:41-7.
25. 25. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;71:2705-14.
26. 26. Marcon L, Choe H, Martin K, et al. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J Virol 1997;71:2522-37.
27. 27. Edinger AL, Amedee A, Miller K, et al. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci USA 1997;94:4005-10.
28. 28. Kirchhoff F, Pöhlmann S, Hamacher M, et al. SIVmac variants with differential T-cell and macrophage tropism use CCR5, and an unidentified cofactor expressed in CEMx174 tells for efficient entry. J Virol 1997;71: 6509-16.
29. 29. Kirchhoff F, Mori K, Desrosiers RC. The "V3" domain is a determinant of SIVmac cell tropism. J Virol 1994;68:3682-92.
30. 30. Regier DA, Desrosiers RC. The complete nucleotide sequence of a pathogenic molecular clone of SIV. AIDS Res Hum Retroviruses 1990;6:1221-31.
31. 31. Alexander L, Du Z, Rosenzweig M, Jung JJ, Desrosiers RC. A role for natural SIV and HIV-1 nef alleles in lymphocyte activation. J Virol 1997;21: 6094-9.
32. 32. Potts BJ. "Mini" reverse transcriptase (RT) assay. In: Aldovini A, Walker BD, eds. Techniques in HIV research. Stockton, NY, 1990;103-6.
33. 33. Kimata JT, Gosink JJ, KewalRamani VN, Rudensey LM, Littman DR, Overbaugh J. Coreceptor specilicity of temporal variants of simian immunodeficiency virus Mne. J Virol 1990;73:1655-60.
34. 34. Chackerian B, Haigwood NL, Overbaugh J. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 1995;213:386-94.
35. |,| N, a novel HIV-2 isolate. AIDS 1990;4:611-7.
36. 36. Stahl-Hennig C, Voss G, Nick S. et al. Immunization with Tweenether treated SIV adsorbed onto aluminun hydroxide protects monkeys against experimental SIV infection. Virology 1992;186:588-96.
37. 37. Ten Haaft P, Verstrepen B, Überla K, Rosenwirth B, Heeney J. A pathogenic threshold of virus load defined in SIV or SHIV infected macaques. J Virol 1998;72:10281-5.
38. 38. Stahl-Hennig C, Dittmer U, Nisslein T, et al. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol 1996;77:2969-81.
39. 39. Edinger AL, Hoffman TL, Sharron M, Lee B, O'Dowd B, Doms RW. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998;249:367-78.
40. 40. Reiprich S, Gundlach BR, Fleckenstein B, Überla K, Replication-competent chimeric Ienti-oneovirus with expanded host cell tropism. J Virol 1997; 71:3328-31.
41. 41. Williams LM, Cloyd MW. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 1991;184:723-8.
42. 42. Overbaugh J, Rudensey LM, Papenhausen MD, Benveniste RE, Morton WR. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J Virol 1991;65:7025-31.
43. 43. Johnson PR, Hamm TE, Goldstein S, Kitov S, Hirsch VM. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology 1991;185:217-28.
44. 44. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997;185:621-8.
45. 45. Chen Z, Kwon D, Jin Z, et al. Natural infection of a homozygous delta 24 CCR5 red-capped mangubey with an R2b-tropic simian immunodeficiency virus. J Exp Med 1998;188:2057-65.
46. 46. Marx PA, Chen Z. The function of simian chemokine receptors in the replication of SIV. Semin Immunol 1998;10:215-23.
47. 47. Chen Z, Gettie A, Ho DD, Marx PA. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in West Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 1998;246:113-24.
48. 48. Kestler HW, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65:651-62.